C4 Therapeutics to Relocate from Kendall Square to LINX in Watertown, MA

Cushman & Wakefield brokers 45,559 sq. ft. lease for Boylston Properties

LINX WatertownC4 Therapeutics, a private biotechnology company currently located in Cambridge will relocate to 45,559 sq. ft. of space within the LINX building in Watertown, announced brokers Cushman & Wakefield and the building owner, Boylston Properties, today.

Located at 490 Arsenal Way, LINX is a 185,000 sq. ft. creative office and lab building in the East End of Watertown, a neighborhood undergoing a tremendous renaissance. The two-story building opened in April 2017 and includes numerous amenities highlighted by an acre of outdoor green and recreation space, a 33’ high lobby area with a café, numerous seating options, bike storage for 78 bicycles, and a high-end shower and locker facility. LINX also offers abundant free parking and a private shuttle bus to Harvard Square and the MBTA Red Line, a 10-12 minute ride.

“The East End of Watertown is the ideal location for C4 Therapeutics,” said Bill McQuillan, President of Boylston Properties. “Not only does the proximity to Boston and Cambridge make the location attractive to technology and life science companies, but the location offers a walkable, urban neighborhood with new housing, retail, restaurants and two new hotels.”

C4 Therapeutics is a privately owned biotech company known for its creation of breakthrough technologies that treat a number of diseases without the issue of drug resistance. With this move from Cambridge to Watertown, C4 Therapeutics is proving growth, innovation, and the advancement of research initiatives is taking place in communities outside of Kendall Square.

“We are very excited about relocating to the LINX building and to calling Watertown our new home,” said Andy Phillips, CEO of C4 Therapeutics. “LINX is a spectacular work environment that offers us the ideal spot to grow as a company. We like the proximity to other biotechs and we are also thrilled to be part of the vision for growth and rejuvenation in and around Arsenal Yards.”

Duncan Gratton, Executive Director for Cushman & Wakefield, and Kate Lien, Senior Director, represented Boylston Properties while C4 Therapeutics was represented by Neil Ross and Tucker Hansen of JLL.

“C4 Therapeutics commitment to LINX is a validation of the East End of Watertown’s location for life science companies that are currently located in Cambridge. stated Cushman & Wakefield’s Gratton. “We have a lot of leasing momentum and are seeing an increasing number of Cambridge lab and technology companies touring LINX. We expect to be signing additional leases in the near future.”

About Boylston Properties

Boylston Properties is a 34-year old Boston-based developer of urban mixed-use projects including retail, residential, hotel, office, and research buildings. The company draws upon urban and suburban development experience on its own or with partners in the Northeast U.S. markets, many in the Greater Boston area. Boylston Properties has recently opened the 150 -room Marriott Residence Inn Boston/Watertown and is redeveloping Arsenal Yards into an exciting mixed-use neighborhood in Watertown’s East End. For more information, please go to  www.boylstonproperties.com or www.linxwatertown.com.

About C4 Therapeutics

C4 Therapeutics is a private biotechnology company developing a new class of drugs based on Targeted Protein Degradation (TPD) to address a broad range of life-threatening and life-impairing diseases. C4T’s Degronimid™ platform uses small molecule drugs to direct the machinery of the ubiquitin-proteasome system to selectively degrade disease-relevant proteins for therapeutic benefit. This distinctive mechanism provides new opportunities to target traditionally difficult-to-treat diseases and diseases plagued by drug resistance. To learn more about C4 Therapeutics, visit www.C4Therapeutics.com.

About Cushman & Wakefield

Cushman & Wakefield is a leading global real estate services firm that helps clients transform the way people work, shop, and live. Our 45,000 employees in more than 70 countries help occupiers and investors optimize the value of their real estate by combining our global perspective and deep local knowledge with an impressive platform of real estate solutions. Cushman & Wakefield is among the largest commercial real estate services firms with revenue of $6 billion across core services of agency leasing, asset services, capital markets, facility services (C&W Services), global occupier services, investment & asset management (DTZ Investors), project & development services, tenant representation, and valuation & advisory. 2017 marks the 100-year anniversary of the Cushman & Wakefield brand. 100 years of taking our clients’ ideas and putting them into action. To learn more, visit www.cushwakecentennial.com, www.cushmanwakefield.com or follow @CushWake on Twitter.

2017-07-12T12:55:33-04:00July 12th, 2017|News, Uncategorized|